Regulation of colony morphology and biofilm formation in Shewanella algae.


Journal

Microbial biotechnology
ISSN: 1751-7915
Titre abrégé: Microb Biotechnol
Pays: United States
ID NLM: 101316335

Informations de publication

Date de publication:
05 2021
Historique:
revised: 15 02 2021
received: 20 08 2020
accepted: 16 02 2021
pubmed: 26 3 2021
medline: 15 5 2021
entrez: 25 3 2021
Statut: ppublish

Résumé

Bacterial colony morphology can reflect different physiological stages such as virulence or biofilm formation. In this work we used transposon mutagenesis to identify genes that alter colony morphology and cause differential Congo Red (CR) and Brilliant Blue G (BBG) binding in Shewanella algae, a marine indigenous bacterium and occasional human pathogen. Microscopic analysis of colonies formed by the wild-type strain S. algae CECT 5071 and three transposon integration mutants representing the diversity of colony morphotypes showed production of biofilm extracellular polymeric substances (EPS) and distinctive morphological alterations. Electrophoretic and chemical analyses of extracted EPS showed differential patterns between strains, although the targets of CR and BBG binding remain to be identified. Galactose and galactosamine were the preponderant sugars in the colony biofilm EPS of S. algae. Surface-associated biofilm formation of transposon integration mutants was not directly correlated with a distinct colony morphotype. The hybrid sensor histidine kinase BarA abrogated surface-associated biofilm formation. Ectopic expression of the kinase and mutants in the phosphorelay cascade partially recovered biofilm formation. Altogether, this work provides the basic analysis to subsequently address the complex and intertwined networks regulating colony morphology and biofilm formation in this poorly understood species.

Identifiants

pubmed: 33764668
doi: 10.1111/1751-7915.13788
pmc: PMC8085958
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1183-1200

Informations de copyright

© 2021 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.

Références

Carbohydr Polym. 2017 Jan 20;156:1-8
pubmed: 27842803
Cell Mol Life Sci. 2005 Jun;62(11):1234-46
pubmed: 15818467
JMM Case Rep. 2017 Dec 7;4(12):e005131
pubmed: 29623211
Eukaryot Cell. 2013 Feb;12(2):194-203
pubmed: 23204192
Nature. 2001 Jul 26;412(6845):442-5
pubmed: 11473319
J Bacteriol. 1991 Aug;173(15):4773-81
pubmed: 1677357
J Intern Med. 2012 Dec;272(6):541-61
pubmed: 23025745
Clin Microbiol Infect. 2005 May;11(5):347-52
pubmed: 15819859
Trends Microbiol. 2009 Mar;17(3):109-18
pubmed: 19231189
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2230-4
pubmed: 20080671
Cell Chem Biol. 2017 May 18;24(5):598-604.e10
pubmed: 28434877
Appl Environ Microbiol. 2001 May;67(5):2319-25
pubmed: 11319118
Infect Immun. 2012 Jun;80(6):2042-52
pubmed: 22451516
Anal Biochem. 1977 Dec;83(2):346-56
pubmed: 603028
Front Bioeng Biotechnol. 2015 Aug 27;3:123
pubmed: 26380258
Infect Immun. 1987 Jun;55(6):1393-8
pubmed: 3553000
Biomolecules. 2017 Oct 31;7(4):
pubmed: 29088115
Front Microbiol. 2015 Oct 06;6:1091
pubmed: 26500631
J Bacteriol. 2004 Jul;186(14):4457-65
pubmed: 15231777
Environ Microbiol Rep. 2016 Feb;8(1):110-21
pubmed: 26617163
Crit Rev Microbiol. 2014 Nov;40(4):293-312
pubmed: 23043419
Anal Biochem. 1994 Jun;219(2):278-87
pubmed: 8080084
J Biol Chem. 2001 Jan 5;276(1):225-31
pubmed: 11022030
Mol Microbiol. 2001 Mar;39(6):1452-63
pubmed: 11260463
Front Cell Infect Microbiol. 2018 Sep 18;8:323
pubmed: 30280093
Annu Rev Microbiol. 2007;61:237-58
pubmed: 18035608
NPJ Biofilms Microbiomes. 2021 Jan 27;7(1):9
pubmed: 33504806
Int J Syst Bacteriol. 1992 Oct;42(4):628-34
pubmed: 1390113
EMBO J. 1994 Nov 1;13(21):5195-202
pubmed: 7957084
Int J Med Microbiol. 2003 Aug;293(4):273-85
pubmed: 14503792
Nat Rev Microbiol. 2010 Sep;8(9):623-33
pubmed: 20676145
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):4028-33
pubmed: 10097157
Environ Microbiol. 2011 Apr;13(4):1018-31
pubmed: 21251176
Sci Rep. 2019 Jan 10;9(1):39
pubmed: 30631105
Front Microbiol. 2020 Jan 31;11:26
pubmed: 32082279
J Clin Microbiol. 1988 Jul;26(7):1343-8
pubmed: 3045151
Front Plant Sci. 2015 Mar 04;6:117
pubmed: 25788899
Anal Bioanal Chem. 2015 Feb;407(5):1433-49
pubmed: 25492090
Mol Microbiol. 2021 Feb;115(2):255-271
pubmed: 32985020
Methods Mol Biol. 2017;1657:225-241
pubmed: 28889298
Water Res. 2019 Nov 1;164:114952
pubmed: 31408759
Pflugers Arch. 2001;443 Suppl 1:S50-4
pubmed: 11845303
J Biotechnol. 2002 May 23;95(3):249-56
pubmed: 12007865
J Appl Microbiol. 2012 Aug;113(2):373-82
pubmed: 22563942
J Bacteriol. 2014 Dec;196(24):4245-52
pubmed: 25266381
Appl Environ Microbiol. 2000 Jan;66(1):443-8
pubmed: 10618264
J Bacteriol. 2004 Dec;186(23):8096-104
pubmed: 15547283
Arch Microbiol. 2002 Sep;178(3):193-201
pubmed: 12189420
FEMS Microbiol Ecol. 2019 Jan 1;95(1):
pubmed: 30339183
J Bacteriol. 2010 Dec;192(24):6418-27
pubmed: 20935093
BMC Microbiol. 2014 Apr 23;14:102
pubmed: 24755232
Mol Microbiol. 1998 Apr;28(2):249-64
pubmed: 9622351
J Bacteriol. 2007 Nov;189(22):7945-7
pubmed: 17675377

Auteurs

Alberto J Martín-Rodríguez (AJ)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Katia Villion (K)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Secil Yilmaz-Turan (S)

Division of Glycoscience, Department of Chemistry, KTH Royal Institute of Technology, AlbaNova University Centre, Stockholm, Sweden.

Francisco Vilaplana (F)

Division of Glycoscience, Department of Chemistry, KTH Royal Institute of Technology, AlbaNova University Centre, Stockholm, Sweden.

Åsa Sjöling (Å)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Ute Römling (U)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH